In addition to adaptive immunity enhancement, it was demonstrated that DCs enhance the anti-tumor function of natural killer cells (NK cells) by increasing their cytolytic activity and the induction of IFN-γ release [61]. This evidence concerns the gene IFNG and neoplasm.